cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Biovie Inc
3 own
4 watching
Current Price
$0.39
$-0.03
(-6.43%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
108.82M
52-Week High
52-Week High
5.82000
52-Week Low
52-Week Low
0.38240
Average Volume
Average Volume
0.49M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization108.82M
icon52-Week High5.82000
icon52-Week Low0.38240
iconAverage Volume0.49M
iconDividend Yield--
iconP/E Ratio--
What does the Biovie Inc do?
BioVie Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of drugs therapies in the United States. Its products in pipeline include BIV201, which completed Phase IIa clinical trial for the treatment of ascites due to chronic liver cirrhosis; and NE3107, which is in Phase III clinical trial for the treatment of patients with mild to moderate Alzheimer s disease and Phase I clinical trial for the treatment of Parkinson's disease. The company is also developing NE3107, which is in pre-clinical stage for the treatment of multiple myeloma and prostate cancer. The company was formerly known as NanoAntibiotics, Inc. and changed its name to BioVie Inc. in July 2016. BioVie Inc. was incorporated in 2013 and is based in Santa Monica, California.
Read More
How much money does Biovie Inc make?
News & Events about Biovie Inc.
Tickeron - Stocks
1 year ago
For the last three days, A.I.dvisor has detected that BIVI's AroonDown red line is above 70 while the AroonUp green line is below 30 for three straight days. This move could indicate a strong...
Globe Newswire
1 year ago
Baseline Data from Phase 3 Trial of NE3107 Presented as Poster at the American Diabetes Association Annual MeetingCARSON CITY, Nev., June 26, 2023 (GLOBE NEWSWIRE) -- BioVie Inc., (NASDAQ: BIVI) (BioVie or the Company) a clinical-stage company developing innovative drug therapies for the treatment ...
Globe Newswire
1 year ago
CARSON CITY, Nev., June 23, 2023 (GLOBE NEWSWIRE) -- BioVie Inc., (NASDAQ: BIVI) (BioVie or the Company) a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disordersand advanced liver disease,today announced that the Company will be ...
Accesswire
1 year ago
ORLANDO, FL / ACCESSWIRE / March 24, 2023 / RedChip Companies will air new interviews with BioVie Inc. (NASDAQ:BIVI) and iRemedy on The RedChip Money Report® on Bloomberg TV, this Saturday, March 25, at 7 p.m. Eastern Time (ET). Bloomberg TV is available in an estimated 73 million homes...
Globe Newswire
1 year ago
CARSON CITY, Nev., March 21, 2023 (GLOBE NEWSWIRE) -- BioVie Inc., (NASDAQ: BIVI) (BioVie or the Company) a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disordersand advanced liver disease,today announceddata from its Phase 2 ...
Frequently Asked Questions
Frequently Asked Questions
What is Biovie Inc share price today?
plus_minus_icon
Can Indians buy Biovie Inc shares?
plus_minus_icon
How can I buy Biovie Inc shares from India?
plus_minus_icon
Can Fractional shares of Biovie Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Biovie Inc stocks?
plus_minus_icon
What is today’s traded volume of Biovie Inc?
plus_minus_icon
What is today’s market capitalisation of Biovie Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Biovie Inc?
plus_minus_icon
What percentage is Biovie Inc down from its 52-Week High?
plus_minus_icon
What percentage is Biovie Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$0.39
$-0.03
(-6.43%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00